Mesa Laboratories, Inc. acquired Beijing GKE Science & Technology Co. LTD for ?5 million
December 30, 2023
Share
Mesa Laboratories, Inc. (NasdaqGS:MLAB) entered into a definitive agreement to acquire Beijing GKE Science & Technology Co. LTD for ?5 million on October 14, 2023. The total purchase price for the acquisition of the entity along with other 2 entities is ?85 million, subject to customary purchase price adjustments and holdbacks. Collectively the three entities are referred to as ?GKE?. ?5 million of the acquisition price, net of cash and debt and subject to customary adjustments will be paid to the sellers upon satisfaction of applicable Chinese regulatory approvals. The transactions were funded through a combination of cash on-hand and $65 million (?61.633 million) borrowed under line of credit. The transaction is expected to be completed during our third quarter ending December 31, 2023.
Mesa Laboratories, Inc. (NASDAQ:MLAB) completed the acquisition of Beijing GKE Science & Technology Co. LTD on December 31, 2023.
Mesa Laboratories, Inc. is a multinational manufacturer, developer, and seller of life sciences tools and critical quality control solutions. Its segments include Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. Its Clinical Genomics segment develops, manufactures, and sells throughput genetic analysis tools used by labs to perform clinical genomic testing in several therapeutic areas. Its Sterilization and Disinfection Control segment manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization and disinfection processes. Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Calibration Solutions segment develops, manufactures, and sells quality control products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters.